Clinical trial
Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With…
NCT00098046 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00098046 |
|---|---|
| Title | Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection |
| Official title | Pharmacokinetics and Safety of Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chickenpox, Herpes Zoster |
| Intervention type | Drug |
| Interventions | famciclovir |
| Enrollment | 76 |
| Start date | Jul 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Dec 3, 2004 |
| Last update posted | Sep 26, 2007 |
| Countries | Costa Rica, Guatemala, Panama, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: